Steven Cohen Axsome Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 378,864 shares of AXSM stock, worth $32.8 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
378,864
Previous 837,201
54.75%
Holding current value
$32.8 Million
Previous $66.6 Million
54.63%
% of portfolio
0.08%
Previous 0.17%
Shares
18 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$389 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$324 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$277 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$204 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$113 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...